Literature DB >> 24142080

Why we should use long-acting injectable antipsychotics more frequently.

João Paulo Maia-de-Oliveira1, Rodrigo A Bressan, Helio Elkis, João Paulo Machado-de-Sousa, Jaime E C Hallak.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 24142080     DOI： 10.1590/1516-4446-2013-3503

Source DB:  PubMed          Journal:  Braz J Psychiatry        ISSN： 1516-4446            Impact factor:   2.697


× No keyword cloud information.
  2 in total

1.  Treatment of Patients with Recently Exacerbated Schizophrenia with Paliperidone Palmitate: A Pilot Study of Efficacy and Tolerability.

Authors:  Wagner F Gattaz; Ricardo Saracco-Alvarez; Claudiane Salles Daltio; Martinus T Van de Bilt; Jose Julian Ortegón; Sergio J Villaseñor-Bayardo; Mario Louzã; Helio Elkis; Bernardo Soares; Patricia Cabrera Jaramillo; Fabio Lawson; Leonardo Díaz-Galvis
Journal:  Neuropsychiatr Dis Treat       Date:  2020-09-10       Impact factor: 2.570

2.  Factors associated with first- versus second-generation long-acting antipsychotics prescribed under ordinary clinical practice in Italy.

Authors:  Giovanni Ostuzzi; Maria Angela Mazzi; Samira Terlizzi; Federico Bertolini; Andrea Aguglia; Francesco Bartoli; Paola Bortolaso; Camilla Callegari; Mariarita Caroleo; Giuseppe Carrà; Mariangela Corbo; Armando D'Agostino; Chiara Gastaldon; Claudio Lucii; Fabio Magliocco; Giovanni Martinotti; Michela Nosé; Edoardo Giuseppe Ostinelli; Davide Papola; Marco Piero Piccinelli; Alberto Piccoli; Marianna Purgato; Tommaso Tabacchi; Giulia Turrini; Mirella Ruggeri; Corrado Barbui
Journal:  PLoS One       Date:  2018-08-02       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.